These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33178539)

  • 1. A Case of 5-Fluorouracil-Induced Coronary Artery Vasospasm in a Patient With Salivary Gland Cancer.
    Dimitrova IN
    Cureus; 2020 Oct; 12(10):e10887. PubMed ID: 33178539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
    Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
    Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.
    Chong JH; Ghosh AK
    Interv Cardiol; 2019 May; 14(2):89-94. PubMed ID: 31178935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
    Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
    Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-fluorouracil and cardiotoxicity: a review.
    Sara JD; Kaur J; Khodadadi R; Rehman M; Lobo R; Chakrabarti S; Herrmann J; Lerman A; Grothey A
    Ther Adv Med Oncol; 2018; 10():1758835918780140. PubMed ID: 29977352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion.
    Redman JM; Rhea LP; Brofferio A; Whelpley M; Gulley JL; Gatti-Mays ME; McMahon S; Cordes LM; Strauss J
    J Gastrointest Oncol; 2019 Oct; 10(5):1010-1014. PubMed ID: 31602339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotoxicity of 5-fluorouracil.
    Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B
    Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasospasm secondary to 5-Fluorouracil and its management: case report.
    Yildirim M; Parlak C; Sezer C; Eryilmaz R; Kaya C; Yildiz M
    Eurasian J Med; 2011 Apr; 43(1):54-6. PubMed ID: 25610161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
    Ray JC; Cho P; Dragon M; Graham CG
    J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST-Segment Elevation Myocardial Infarction Caused by 5-Fluorouracil-Related Cardiotoxicity.
    Balaji N; Dixit P; Adams AM; Faiz F; Ngwainmbi D; Henry G; Ghasemzadeh N
    Cureus; 2024 Jan; 16(1):e52864. PubMed ID: 38406077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
    Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
    Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
    Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoropyrimidine-associated cardiotoxicity: revisited.
    Saif MW; Shah MM; Shah AR
    Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
    Fabin N; Bergami M; Cenko E; Bugiardini R; Manfrini O
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.
    Zafar A; Drobni ZD; Mosarla R; Alvi RM; Lei M; Lou UY; Raghu VK; Murphy SP; Jones-O'Connor M; Hartmann S; Gilman HK; Weekes CD; Clark JR; Clark J; Blaszkowsky L; Tavares E; Neilan TG
    JACC CardioOncol; 2021 Mar; 3(1):101-109. PubMed ID: 33817666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-fluorouracil-induced coronary vasospasm.
    Shoemaker LK; Arora U; Rocha Lima CM
    Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of 5-flourouracil: two case reports.
    Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
    Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen.
    Cerny J; Hassan A; Smith C; Piperdi B
    Clin Colorectal Cancer; 2009 Jan; 8(1):55-8. PubMed ID: 19203898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.